0001209191-19-007764.txt : 20190206
0001209191-19-007764.hdr.sgml : 20190206
20190206164751
ACCESSION NUMBER: 0001209191-19-007764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190204
FILED AS OF DATE: 20190206
DATE AS OF CHANGE: 20190206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 19572056
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2019-02-04
4
S
0
1300
184.99
D
155815
D
Common Stock
2019-02-04
4
S
0
17099
186.10
D
138716
D
Common Stock
2019-02-04
4
S
0
12951
186.70
D
125765
D
Common Stock
2019-02-04
4
S
0
900
187.91
D
124865
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $184.99 (range $184.49 to $185.38).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $186.10 (range $185.55 to $186.38).
Open market sales reported on this line occurred at a weighted average price of $186.70 (range $186.39 to $187.29).
Open market sales reported on this line occurred at a weighted average price of $187.91 (range $187.51 to $188.25).
/s/ Omar White, Attorney-in-Fact
2019-02-06